Skip to main content
DBD
NYSE Technology

Diebold Nixdorf Reports Strong FY25 Results, Doubles Free Cash Flow, and Raises 2026 Outlook

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$72.36
Mkt Cap
$2.595B
52W Low
$34.875
52W High
$73.51
Market data snapshot near publication time

summarizeSummary

Diebold Nixdorf announced strong full-year 2025 financial results, including doubled free cash flow and adjusted EPS, a credit rating upgrade, and a new share repurchase program, alongside an optimistic 2026 outlook that surpasses prior targets.


check_boxKey Events

  • Strong FY25 Financial Performance

    Reported full-year 2025 revenue growth of approximately 1.5%, adjusted EBITDA growth of 7.2% to $485 million, and more than doubled free cash flow to $239 million and adjusted EPS to $5.59.

  • Raised 2026 Financial Outlook

    Established a new 2026 financial outlook with total revenue guidance of $3.86B - $3.94B, adjusted EBITDA of $510M - $535M, and adjusted EPS of $5.25 - $5.75, which is above previous targets.

  • Credit Rating Upgrade

    Received a credit rating upgrade to B1 from B2 from Moody's Ratings, reflecting the company's strengthened financial profile.

  • Share Repurchase Program

    Initiated a new $200 million share repurchase program, following the completion of an initial $100 million program in Q4 2025, having repurchased approximately $128 million of shares (about 6% of total shares outstanding) in FY 2025.


auto_awesomeAnalysis

Diebold Nixdorf reported robust financial performance for fiscal year 2025, demonstrating significant growth across key metrics. The company achieved revenue growth, expanded adjusted EBITDA, and more than doubled its free cash flow and adjusted EPS year-over-year. This strong operational execution led to a credit rating upgrade from Moody's, signaling improved financial health. Furthermore, the company initiated a new $200 million share repurchase program after completing an initial $100 million program, returning capital to shareholders. The established 2026 financial outlook is positive, exceeding previous targets, which is particularly notable as the stock is currently trading near its 52-week high, reflecting strong investor confidence.

At the time of this filing, DBD was trading at $72.36 on NYSE in the Technology sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $34.88 to $73.51. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DBD - Latest Insights

DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Apr 10, 2026, 4:04 PM EDT
Filing Type: 4
Importance Score:
7
DBD
Feb 12, 2026, 4:38 PM EST
Filing Type: 10-K
Importance Score:
9
DBD
Feb 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
DBD
Jan 20, 2026, 4:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Jan 20, 2026, 4:10 PM EST
Filing Type: 4
Importance Score:
7
DBD
Jan 15, 2026, 4:40 PM EST
Filing Type: 144
Importance Score:
7